LAKE OSWEGO, Ore.-- (BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration (FDA) has granted approval for its ...

Biotronik is looking to get the FDA's approval for a line of MRI-safe pacemakers--courtesy of Biotronik The FDA approved a clinical trial of Biotronik's proMRI pacemaker, a device designed to operate ...

LAKE OSWEGO, Ore., Aug. 29, 2023 /PRNewswire/ -- BIOTRONIK, a leader in implantable medical device technology, today announced its first US implantation of the new Amvia Edge pacemaker. The procedure ...

On November 6, at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 14th Annual European Congress in Madrid, Spain, BIOTRONIK presented a series of four posters ...

Global manufacturer of cardiovascular medical devices BIOTRONIK announced the release of its Renamic product for the Japanese market. The announcement is in response to the dramatic growth of cardiac ...

LAKE OSWEGO, Ore., Aug. 31, 2022 /PRNewswire/ -- BIOTRONIK's LiveSupport feature has been successfully used to remotely support Cardiac Rhythm Management (CRM) clinics. This new technology enables ...

LAKE OSWEGO, Ore., July 6, 2023 /PRNewswire/ -- BIOTRONIK today announced U.S. Food and Drug Administration (FDA) approval of its portfolio of Amvia Edge pacemakers and cardiac resynchronization ...

Materials supplier Syensqo announced today that its Eviva-branded polysulfone (PSU) has been selected by medical device OEM Biotronik for use in the header of its latest Amvia Sky pacemaker models.